Caprolactam Chemicals Limited Announces Postal Ballot Calendar for Director Remuneration and Related Party Transactions

3 min read     Updated on 25 Feb 2026, 03:05 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Caprolactam Chemicals Limited has issued a postal ballot notice seeking shareholder approval for four resolutions including remuneration revisions for CFO Mr. Siddharth Bhanushali and MD Ms. Zaver Bhanushali, property leasing with Ms. Shital Bhanushali, and consultancy fee revision for Mr. Shankar Bhanushali. The e-voting process will run from February 28 to March 29, 2026.

33557753

*this image is generated using AI for illustrative purposes only.

Caprolactam Chemicals Limited has issued a comprehensive postal ballot notice dated February 25, 2026, seeking shareholder approval for significant corporate governance matters including director remuneration revisions and related party transactions. The company has also released the official calendar of events for the postal ballot process.

Postal Ballot Resolutions Overview

The company has proposed four key resolutions for shareholder consideration, comprising two special resolutions and two ordinary resolutions:

Resolution No.: Description Type
1 Revision in Remuneration of Mr. Siddharth Shankarlal Bhanushali (CFO cum Whole-Time Director) Special Resolution
2 Revision in Remuneration of Ms. Zaver Shankarlal Bhanushali (Managing Director) Special Resolution
3 Related Party Transaction with Ms. Shital Bhanushali for Property Leasing Ordinary Resolution
4 Revision in Consultancy Fees for Mr. Shankar Bhanushali Ordinary Resolution

Director Remuneration Revisions

The Board of Directors, based on recommendations from the Nomination and Remuneration Committee at their meeting held on February 13, 2026, has approved significant remuneration revisions for key executive positions.

Chief Financial Officer cum Whole-Time Director

Mr. Siddharth Shankarlal Bhanushali's revised compensation structure includes:

Component: Details
Basic Salary: Rs. 2,00,000 per month
Allowances & Perquisites: As per Company policy
Variable Pay/Performance Incentive: As approved by Board/NRC
Other Benefits: As applicable to senior management
Effective Date: April 1, 2026

Managing Director

Ms. Zaver Shankarlal Bhanushali's revised remuneration package encompasses:

Component: Details
Basic Salary: Rs. 1,50,000 per month
Allowances & Perquisites: As per Company policy
Performance-linked Incentive/Commission: As determined by Board and NRC
Other Benefits: As applicable to Managing Director
Effective Date: April 1, 2026

Related Party Transactions

Property Leasing Arrangement

The company seeks approval for a property leasing transaction with Ms. Shital Bhanushali for office premises:

Parameter: Details
Property Description: 339 sq feet carpet area, 11th Room Number, Vaishali Apartment
Location: 353/2B, R. B. Mehta Marg, Ghatkopar (E) Mumbai
Monthly Rent: Rs. 65,000 (exclusive of taxes)
Security Deposit: NIL
Tenure: 36 months
Escalation: 10% increase after every 12 months
Purpose: Office Use

Consultancy Fee Revision

The board proposes revising consultancy fees for Mr. Shankar Bhanushali's liaisoning and consultancy services:

Fee Structure: Amount
Existing Consultancy Fee: Rs. 50,000 per month
Revised Consultancy Fee: Rs. 80,000 per month
Effective Date: April 1, 2026
Tenure: 36 months
Service Nature: Liaisoning and consultancy for process plant purposes

Postal Ballot Calendar and E-Voting Timeline

The company has released the official calendar of events for the postal ballot process, which will be conducted exclusively through remote e-voting using Purva Sharegistry (India) Private Limited's platform:

Event: Date/Details
Scrutinizer Appointment: February 14, 2026
Cut-off Date: February 20, 2026
Notice Dispatch Completion: February 25, 2026
E-voting Commencement: February 28, 2026 at 10:00 a.m. (IST)
E-voting Conclusion: March 29, 2026 at 5:00 p.m. (IST)
Scrutinizer Report Submission: March 30, 2026
Results Declaration: March 30, 2026

Mr. Rahul Gori has been appointed as the Scrutinizer to conduct the postal ballot process and scrutinize votes in a fair and transparent manner.

Compliance and Regulatory Framework

All proposed resolutions comply with applicable provisions of the Companies Act, 2013, SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and relevant MCA circulars. The transactions are structured to be conducted at arm's length basis and in the ordinary course of business. Interested related parties, including the directors and their relatives mentioned in the resolutions, will abstain from voting in accordance with regulatory requirements.

Caprolactam Chemicals Limited Schedules Board Meeting for February 13, 2026 to Review Q3FY26 Results and Dividend Recommendation

1 min read     Updated on 27 Jan 2026, 05:38 PM
scanx
Reviewed by
Ashish TScanX News Team
Overview

Caprolactam Chemicals Limited has scheduled its Board of Directors meeting for February 13, 2026, at 4:00 PM to consider and approve unaudited financial results for the quarter ended December 31, 2025, and evaluate dividend recommendations on equity shares. The company has implemented trading window restrictions for designated persons and their relatives, effective from January 1, 2026, until 48 hours after the financial results declaration, in compliance with insider trading regulations.

31061291

*this image is generated using AI for illustrative purposes only.

Caprolactam Chemicals Limited has formally announced its Board of Directors meeting scheduled for February 13, 2026, to review the company's quarterly financial performance and consider dividend distribution to shareholders.

Board Meeting Details

The company has communicated to BSE Limited regarding the upcoming board meeting, which will be held on Friday, February 13, 2026, at 4:00 PM. The meeting agenda includes two primary items for consideration and approval.

Meeting Parameter: Details
Date: February 13, 2026
Time: 4:00 PM
Primary Agenda: Q3FY26 unaudited financial results
Secondary Agenda: Dividend recommendation on equity shares
Quarter Period: December 31, 2025

Financial Results and Dividend Consideration

The board will deliberate on the unaudited financial results for the quarter ended December 31, 2025, marking the third quarter of the financial year 2026. Additionally, the directors will evaluate and potentially recommend dividend payment on equity shares, subject to the company's financial performance and available reserves.

Trading Window Restrictions

In compliance with regulatory requirements, Caprolactam Chemicals Limited has implemented trading window restrictions for designated persons and their relatives. The company has established these measures pursuant to its code to regulate, monitor and report trading by insiders.

Trading Window Details: Information
Closure Start Date: January 1, 2026
Closure End: 48 hours after financial results declaration
Applicable To: Designated persons and their relatives
Regulatory Basis: Company's insider trading code

Regulatory Compliance

The announcement has been made in accordance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The communication was signed by Siddharth Shankarlal Bhanushali, Director of the company, bearing DIN: 01721586, and dated January 27, 2026.

The company has requested BSE Limited to inform its members about the scheduled board meeting and associated trading restrictions, ensuring transparency and regulatory compliance in its corporate governance practices.

More News on Caprolactam Chemicals